Compare DEA & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DEA | CNMD |
|---|---|---|
| Founded | 2011 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2014 | 1995 |
| Metric | DEA | CNMD |
|---|---|---|
| Price | $23.93 | $34.65 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 5 |
| Target Price | $23.49 | ★ $46.25 |
| AVG Volume (30 Days) | 309.5K | ★ 404.7K |
| Earning Date | 04-27-2026 | 04-29-2026 |
| Dividend Yield | ★ 7.77% | 1.11% |
| EPS Growth | ★ 50.00 | N/A |
| EPS | 0.02 | ★ 1.51 |
| Revenue | $336,099,000.00 | ★ $1,374,724,000.00 |
| Revenue This Year | $5.41 | $0.82 |
| Revenue Next Year | $3.33 | $5.48 |
| P/E Ratio | $1,193.00 | ★ $24.04 |
| Revenue Growth | ★ 11.27 | 5.18 |
| 52 Week Low | $20.56 | $32.13 |
| 52 Week High | $24.94 | $56.64 |
| Indicator | DEA | CNMD |
|---|---|---|
| Relative Strength Index (RSI) | 54.54 | 45.23 |
| Support Level | $23.46 | $32.67 |
| Resistance Level | $24.36 | $38.60 |
| Average True Range (ATR) | 0.38 | 1.60 |
| MACD | -0.01 | 0.09 |
| Stochastic Oscillator | 46.73 | 40.72 |
Easterly Government Properties Inc is a real estate investment trust. The company is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. It generates all its revenue by leasing its properties to such agencies. The company operates in single segment for the purposes of assessing performance and making operating decisions.
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.